Comparison of cryoprecipitate with fibrinogen concentrate for acquired hypofibrinogenaemia

被引：25

作者：

Theodoulou, A. ^{[1
]}

Berryman, J. ^{[1
]}

Nathwani, A. ^{[1
,2
]}

Scully, M. ^{[1
]}

机构：

[1] UCLH, Dept Pathol, London, England

[2] UCL, Dept Haematol, London, England

来源：

TRANSFUSION AND APHERESIS SCIENCE | 2012年 / 46卷 / 02期

关键词：

Cryoprecipitate; Fibrinogen concentrate; Acquired hypofibrinogenaemia; PLASMA; TOLERABILITY; DEFICIENCY; GUIDELINES; MANAGEMENT; EFFICACY;

D O I：

10.1016/j.transci.2011.11.005

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Background: The benefits of fibrinogen concentrate in hypofibrinogenaemia have been established in congenital and has been used in acquired disorders. Most European countries have already changed their practice, using fibrinogen concentrate. Methods: We compared the use of fibrinogen concentrate in acquired hypofibrinogenaemia to cryoprecipitate, which continues to be the standard of care in the UK. We undertook a retrospective analysis of fibrinogen increment in patients treated for acquired hypofibrinogenaemia. Results: Sixty four transfusion episodes receiving cryoprecipitate and 36 episodes receiving fibrinogen concentrate were compared. The median increment following 10 donor pools (two bags) of cryoprecipitate was 0.26 g/l, compared to 0.44 g/l following 2 g of fibrinogen concentrate. Conclusion: With its superior safety profile from infectious diseases, this provides further evidence to support the use of fibrinogen concentrate. (C) 2011 Elsevier Ltd. All rights reserved.

引用

页码：159 / 162

页数：4

共 50 条

[31] Do we still need cryoprecipitate? Cryoprecipitate and fibrinogen concentrate as treatments for major hemorrhage how do they compare?
Novak, Alex
Stanworth, Simon J.
Curry, Nicola
EXPERT REVIEW OF HEMATOLOGY, 2018, 11 (05) : 351 - 360
[32] CRYOPRECIPITATE AND FIBRINOGEN
GOODNIGHT, SH
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1979, 241 (16): : 1716 - 1717
[33] Differences in coagulation-relevant parameters: Comparing cryoprecipitate and a human fibrinogen concentrate
Stanford, Sophia
Roy, Ashok
Cecil, Tom
Hegener, Oliver
Schulz, Petra
Turaj, Anna
Lim, Sean
Arbuthnot, Emily
PLOS ONE, 2023, 18 (08):
[34] Comparing efficacy and safety of fibrinogen concentrate to cryoprecipitate in bleeding patients: a systematic review
Jensen, N. H. L.
Stensballe, J.
Afshari, A.
ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2016, 60 (08) : 1033 - 1042
[35] Fibrinogen concentrate and cryoprecipitate but not fresh frozen plasma correct low fibrinogen concentrations following in vitro haemodilution
Fenger-Eriksen, Christian
Christiansen, Kirsten
Laurie, John
Sorensen, Benny
Rea, Catherine
THROMBOSIS RESEARCH, 2013, 131 (05) : E210 - E213
[36] The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric haemorrhage - an observational study
Ahmed, S.
Harrity, C.
Johnson, S.
Varadkar, S.
McMorrow, S.
Fanning, R.
Flynn, C. M.
O' Riordan, J. M.
Byrne, B. M.
TRANSFUSION MEDICINE, 2012, 22 (05) : 344 - 349
[37] Successful pregnancy outcomes in two women with symptomatic hypofibrinogenaemia, following treatment with fibrinogen concentrate.
Sefcick, A
Stirling, D
Ludlam, CA
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 105 : 48 - 48
[38] Preoperative replacement therapy with fibrinogen concentrate in a patient with Klippel-Trenaunay syndrome and severe hypofibrinogenaemia
Coloma-Perez, M.
Hernandez-Palazon, J.
Fuentes-Garcia, D.
Falcon-Arana, L.
BRITISH JOURNAL OF ANAESTHESIA, 2013, 110 (05) : 855 - 856
[39] The fibres study: a phase 3, non-inferiority, randomized comparison of a new fibrinogen concentrate vs. cryoprecipitate for treating acquired hypofibrinogenemia in bleeding cardiac surgical patients
Karkouti, K.
HAEMOPHILIA, 2018, 24 : 96 - 96
[40] Cryoprecipitate AHF vs. fibrinogen concentrates for fibrinogen replacement in acquired bleeding patients - an economic evaluation
Okerberg, C. K.
Williams, L. A., III
Kilgore, M. L.
Kim, C. H.
Marques, M. B.
Schwartz, J.
Pham, H. P.
VOX SANGUINIS, 2016, 111 (03) : 292 - 298

← 1 2 3 4 5 →